Key Highlights

Risk & Performance

Pipeline Risk Assessment

Pipeline Risk Assessment

Based on historical performance

Moderate Risk

Score: 55/100

Failure Rate

22.2%

4 terminated/withdrawn out of 18 trials

Success Rate

75.0%

-11.5% vs industry average

Late-Stage Pipeline

67%

12 trials in Phase 3/4

Results Transparency

17%

2 of 12 completed trials have results

Key Signals

2 with results

Enrollment Performance

Analytics

Phase 3
12(66.7%)
Phase 2
4(22.2%)
Phase 1
2(11.1%)
18Total
Phase 3(12)
Phase 2(4)
Phase 1(2)

Activity Timeline

Global Presence

Loading network data...

Clinical Trials (18)

Showing 18 of 18 trials
NCT06608641Phase 3Active Not Recruiting

Efficacy and Safety of Endoxifen in Bipolar I Disorder Patients

Role: collaborator

NCT06867042Phase 2Not Yet Recruiting

Tacrolimus Lipid Suspension for Enema in Adult Subjects with Mild to Moderately Active Left-sided/Distal Ulcerative Colitis Who Had an Inadequate Response to the Treatment

Role: collaborator

NCT04315792Phase 3Completed

Evaluate Efficacy and Safety of Endoxifen in Bipolar I Disorder Patients

Role: collaborator

NCT03298581Phase 2Withdrawn

Multiple-Dose Pharmacokinetics and Potential for Adrenal Suppression Following Treatment With Halobetasol Spray in Patients With Plaque Psoriasis

Role: collaborator

NCT04203342Phase 3Completed

A Therapeutic Equivalence Study of Ketoconazole Cream 2%

Role: collaborator

NCT03245385Phase 2Terminated

Multiple-Dose Pharmacokinetics and Potential for Adrenal Suppression Following Treatment With Halobetasol Spray in Patients With Atopic Dermatitis

Role: collaborator

NCT03824912Phase 3Completed

Clinical Study to Evaluate the Therapeutic Equivalence of Ketoconazole Cream 2% in the Treatment of Tinea Pedis

Role: collaborator

NCT03178942Phase 3Completed

Multiple-Site Study to Evaluate the Therapeutic Equivalence of Permethrin Cream, 5% in the Treatment of Scabies

Role: collaborator

NCT03826550Phase 3Completed

Therapeutic Equivalence of Diclofenac Sodium Gel 3% vs Solaraze ® in the Treatment of Actinic Keratosis

Role: collaborator

NCT00653003Phase 1Completed

Bioavailability Study of Leflunomide Tablets Under Fed Conditions

Role: collaborator

NCT01994642Phase 3Terminated

Bioequivalence of Two Ciprofloxacin 0.3%/Dexamethasone 0.1% Sterile Otic Suspensions in Otitis Media in Children With Tympanostomy Tubes

Role: collaborator

NCT01910155Phase 3Terminated

A Bioequivalence Study of Two Ciprofloxacin/Dexamethasone Formulations in Patients With Otitis Externa

Role: collaborator

NCT02572986Phase 3Completed

A Study to Evaluate the Therapeutic Equivalence of Generic Permethrin Cream 5% to Elimite® in the Treatment of Scabies

Role: collaborator

NCT02125253Phase 3Completed

Study to Compare the Therapeutic Equivalence of Mometasone Furoate Nasal Spray, 50 mcg With Nasonex Nasal Spray in the Relief of the Signs and Symptoms of Seasonal Allergic Rhinitis

Role: collaborator

NCT01372423Phase 3Completed

Evaluation of Clinical Equivalence Between Two Lubiprostone Products

Role: collaborator

NCT01456611Phase 3Completed

Evaluation of Clinical Endpoints of Two Diclofenac Sodium Gel 1%

Role: collaborator

NCT01367314Phase 2Completed

Safety and Efficacy of Topical NVC-422 Gel in Impetigo

Role: collaborator

NCT00652665Phase 1Completed

Bioavailability Study of Leflunomide Tablets Under Fasting Conditions

Role: collaborator

All 18 trials loaded